BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
51.17
0.79 (1.57%)
At close: Aug 14, 2025, 3:59 PM
51.20
0.06%
Pre-market: Aug 15, 2025, 09:04 AM EDT
BridgeBio Pharma Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for BBIO stock have an median target of 59, with a low estimate of 46 and a high estimate of 95. The median target predicts an increase of 15.30% from the current stock price of 51.17.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 46 | 61.69 | 59 | 95 |
| Change | -10.10% | 20.56% | 15.30% | 85.66% |
Latest Analyst Insight Report
Scotiabank maintains a Sector Outperform rating on... Unlock content with Pro Subscription
Updated Aug 06, 2025
| Rating | Feb 25 | Mar 25 | Apr 25 | Jun 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 2 | 2 | 1 | 0 |
| Buy | 5 | 2 | 2 | 2 | 5 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 2 | 4 | 4 | 6 | 2 |
Financial Forecast this Year
Revenue This Year
468.55M
from 221.9M
Increased by 111.2%
Revenue Next Year
801.14M
from 468.55M
Increased by 71.0%
EPS This Year
-3.52
from -2.88
Increased by -22.2%
EPS Next Year
-1.82
from -3.52
Increased by 48.3%